K CHATTERJEE, TA PORTS, BH BRUNDAGE … - Annals of Internal Medicine, 1980 - Am Coll Physicians Hemodynamic effects of oral hydralazine (200 to 400 mg/d) were evaluated in 11
patients with chronic heart failure after short-term (24 hours) and long-term
(average, 8.3 months) therapy. In seven of 11 patients, hemodynamic changes ... Cited by 41 - Related articles - All 2 versions
CR McKay, K Chatterjee, TA Ports, AN Holly … - American heart journal, 1982 - ncbi.nlm.nih.gov The hemodynamic response to minoxidil, an orally active, potent vasodilator, was
evaluated in 11 patients with severe chronic congestive heart failure (CHF). The
hemodynamic response was determined following single doses of 10, 15, 20, ... Cited by 18 - Related articles
KT Weber, GT Kinasewitz, JS West, JS … - New England Journal of Medicine, 1980 - content.nejm.org Patients with cardiac failure have a generalized sympathetic vasoconstriction
that may impair cardiac function and exercise tolerance. The ability of
long-term alpha-receptor blockade and vasodilation with trimazosin (TMZ) to ... Cited by 50 - Related articles - All 2 versions
JA Franciosa, LA Nordstrom, JN Cohn - JAMA, 1978 - Am Med Assoc A randomized double-blind crossover trial included 16 patients with severe
congestive heart failure who received isosorbide dinitrate or placebo for eight
weeks, and then the opposite treatment for eight more weeks. All patients ... Cited by 95 - Related articles - All 2 versions
M Packer, J Meller, N Medina, M Yushak, R … - New England Journal of Medicine, 1982 - content.nejm.org We performed hemodynamic studies in 11 patients with severe chronic heart
failure whose symptoms had returned to their pretreatment status after 37 +/- 15
weeks (mean +/- SEM) of therapy with the vasodilator hydralazine. The ... Cited by 55 - Related articles - All 2 versions
- ►ahajournals.org [PDF] JA Franciosa, JN Cohn - Circulation, 1981 - Am Heart Assoc SUMMARY Vasodilators used in chronic congestive heart failure are not optimal in
that nitrates are ... 1/min/m2 after minoxidil (p < 0.02) and systemic vascular
resistance fell from 19.6 ± 1.5 to 15.0 ± 1.3 units Cited by 30 - Related articles - All 3 versions
DH Fitchett, JA Neto, CM Oakley, JF Goodwin - The American journal of cardiology, 1979 - ncbi.nlm.nih.gov 1: Am J Cardiol. 1979 Aug;44(2):303-9. Hydralazine in the management of left
ventricular failure. Fitchett DH, Neto JA, Oakley CM, Goodwin JF. ... Cited by 46 - Related articles
JA Franciosa, KT Weber, TB Levine, GT … - American heart journal, 1982 - ncbi.nlm.nih.gov Although hydralazine improves cardiac performance in patients with chronic left
ventricular failure, its long-term clinical efficacy has not been established in
controlled trials. We carried out a double-blind randomized trial of ... Cited by 88 - Related articles
TB Conradson, L Rydén - Acta medica Scandinavica. Supplementum, 1981 - ncbi.nlm.nih.gov 1: Acta Med Scand Suppl. 1981;652:173-6. Sustained effect of hydralazine
in long term treatment of CHF. Conradson TB, Rydén L. ... Cited by 5 - Related articles - All 2 versions
- ►nih.gov [PDF] P Daly, JL Rouleau, D Cousineau, JH Burgess … - British Medical Journal, 1986 - heart.bmj.com Page 1. doi:10.1136/hrt.56.2.152 1986;56;152-157 Heart Chatterjee P Daly,
JL Rouleau, D Cousineau, JH Burgess and K failure. patients ... Cited by 10 - Related articles - All 6 versions
